Clinical Value of Routine Serum Squamous Cell Carcinoma Antigen in Follow-Up of Patients With Early-Stage Cervical Cancer
Authors:
- 1 October 2001
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 19 (19) , 3960-3966
Abstract
PURPOSE: To investigate the contribution to recurrence detection and survival of serum squamous cell carcinoma antigen (SCC-ag) analysis in the follow-up of early-stage cervical cancer patients. PATIENTS AND METHODS: Follow-up data were evaluated in patients with early-stage squamous cell cervical cancer treated by radical hysterectomy and pelvic lymphadenectomy with or without radiotherapy. Routine serum SCC-ag determination was performed at each follow-up visit. RESULTS: Recurrent disease occurred in 35 (16%) of 225 patients and was preceded or accompanied by serum SCC-ag elevation 26 times (sensitivity, 74%). In five (14%) of these 35 patients, elevated serum SCC-ag was the first measured clinical indicator. Desite salvage therapy, all five patients died of disease. In the other 31 patients (21 with serum SCC-ag elevation), either symptoms and/or positive signs led to recurrence detection. Median survival time after recurrence was worse (9 months; range, 2 to 112+) for patients with an elevated serum SCC-ag value at recurrence in comparison with patients with normal serum SCC-ag values (20 months; range, 4 to 96; P < .01). In 23 of the 190 patients without recurrences, serum SCC-ag values became falsely elevated. In 16 of these 23 patients, the repeat sample after 6 weeks showed a normal SCC-ag, and in seven patients benign (especially skin) disorders were found. CONCLUSION: Serum SCC-ag analysis results in earlier recurrence detection in a small proportion (14%) of patients but did not contribute to better survival. As long as treatment possibilities for recurrent cervical cancer patients are not improved, serum SCC-ag analysis should not be carried out in routine follow-up.Keywords
This publication has 10 references indexed in Scilit:
- The Clinical Value of Squamous Cell Carcinoma Antigen in Cancer of the Uterine CervixTumor Biology, 1998
- Prognostic Value of Preoperative Squamous Cell Carcinoma Antigen Level in Patients Surgically Treated for Cervical CarcinomaGynecologic Oncology, 1997
- Recurrent Stage IB cervical carcinoma: evaluation of the effectiveness of routine follow up surveillanceBJOG: An International Journal of Obstetrics & Gynaecology, 1996
- Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma.Journal of Clinical Oncology, 1996
- Correlation of squamous cell carcinoma antigen levels and treatment response in cervical cancerGynecologic Oncology, 1991
- Is there a role for adjuvant pelvic radiotherapy after radical hysterectomy in early stage cervical cancer?International Journal of Gynecological Cancer, 1991
- Cancer of the uterine cervix: Sensitivity and specificity of serum squamous cell carcinoma antigen determinationsGynecologic Oncology, 1990
- Relapse patterns in FIGO stage IB carcinoma of the cervixGynecologic Oncology, 1990
- Tumor-antigen TA-4 in the detection of recurrence in cervical squamous cell carcinomaCancer, 1984
- Recurrent cancer of the cervix following radical hysterectomy and pelvic node dissectionGynecologic Oncology, 1980